Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors.
Faggiano A, Russo F, Zamponi V, Sesti F, Puliani G, Modica R, Malandrino P, Ferraù F, Rinzivillo M, Di Muzio M, Di Simone E, Panattoni N, Dolce P, Lauretta R, Di Iasi G, Prinzi A, Alessi Y, Feola T, Mazzilli R, Appetecchia M, Giannetta E, Panzuto F, Colao A. Faggiano A, et al. Among authors: malandrino p. J Neuroendocrinol. 2024 Dec 26:e13485. doi: 10.1111/jne.13485. Online ahead of print. J Neuroendocrinol. 2024. PMID: 39726194
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
Muscogiuri G, Altieri B, Albertelli M, Dotto A, Modica R, Barrea L, Fanciulli G, Feola T, Baldelli R, Ruggeri RM, Gallo M, Guarnotta V, Malandrino P, Messina E, Venneri MA, Giannetta E, Ferone D, Colao A, Faggiano A; NIKE group. Muscogiuri G, et al. Among authors: malandrino p. Endocrine. 2020 Aug;69(2):441-450. doi: 10.1007/s12020-020-02331-3. Epub 2020 May 28. Endocrine. 2020. PMID: 32468269
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications.
Vitale G, Cozzolino A, Malandrino P, Minotta R, Puliani G, Saronni D, Faggiano A, Colao A. Vitale G, et al. Among authors: malandrino p. Front Endocrinol (Lausanne). 2021 Apr 14;12:665631. doi: 10.3389/fendo.2021.665631. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33935975 Free PMC article. Review.
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.
Ruggeri RM, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, Brizzi MP, Zumstein L, Pia A, Lania A, Lavezzi E, Nappo G, Laffi A, Albertelli M, Boschetti M, Hasballa I, Veresani A, Prinzi N, Pusceddu S, Oldani S, Nichetti F, Modica R, Minotta R, Liccardi A, Cannavale G, Grossrubatscher EM, Tarsitano MG, Zamponi V, Zatelli MC, Zanata I, Mazzilli R, Appetecchia M, Davì MV, Guarnotta V, Giannetta E, La Salvia A, Fanciulli G, Malandrino P, Isidori AM, Colao A, Faggiano A; NIKE Group. Ruggeri RM, et al. Among authors: malandrino p. J Endocrinol Invest. 2024 Apr;47(4):959-971. doi: 10.1007/s40618-023-02213-1. Epub 2023 Oct 14. J Endocrinol Invest. 2024. PMID: 37837555 Free PMC article.
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.
Faggiano A, Malandrino P, Modica R, Agrimi D, Aversano M, Bassi V, Giordano EA, Guarnotta V, Logoluso FA, Messina E, Nicastro V, Nuzzo V, Sciaraffia M, Colao A. Faggiano A, et al. Among authors: malandrino p. Oncologist. 2016 Jul;21(7):875-86. doi: 10.1634/theoncologist.2015-0420. Epub 2016 Apr 6. Oncologist. 2016. PMID: 27053503 Free PMC article. Review.
74 results